Ceribell

CeribellCeribell
Ceribell

Ceribell

AI-powered EEG device for rapid seizure detection in critical care.

Website
2014Active397Sunnyvale, United States
Rate
Advertise here

About

Ceribell is a medical technology company that developed an AI-powered electroencephalogram (EEG) system designed for rapid and accurate seizure detection in hospital settings. Their system aims to provide clinicians with faster insights into brain activity, improving patient care and outcomes in critical situations.

Technology stack

detected 2026-07-12
Email
Hosting
Stack
Analytics
Cookie consent
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Ceribell do?

Ceribell is a medical technology company that developed an AI-powered electroencephalogram (EEG) system designed for rapid and accurate seizure detection in hospital settings. Their system aims to provide clinicians with faster insights into brain activity, improving patient care and outcomes in critical situations.

How much funding has Ceribell raised?

Ceribell has raised a total of $1M in funding. The most recent round on record is Seed.

Where is Ceribell headquartered?

Ceribell is headquartered in Sunnyvale, United States.

When was Ceribell founded?

Ceribell was founded in 2014.

What industry does Ceribell operate in?

Ceribell operates in MedTech, HealthTech, AI-Driven Protein Design, Clinical Trials, Digital Twin Healthcare, AI Infrastructure.

How many employees does Ceribell have?

Ceribell has approximately 397 people on record.

What is Ceribell's revenue?

StartupHub estimates Ceribell's annual revenue at $125.5M (range $67.4M to $245.9M, 62% confidence), based on comparable companies in the sector.

What is Ceribell's valuation?

StartupHub estimates Ceribell's effective valuation at $4.2M (range $2.5M to $6.0M, 10% confidence), based on comparable companies in the sector.